ArticlePoultry science2026
Wildlife-derived Lactobacillus agilis LA-V4 alleviates Salmonella Typhimurium infection in broilers through gut microbiota remodeling and hepatic autophagy restoration.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Salmonella Typhimurium (S. Typhimurium) is a major enteric pathogen in poultry production, causing substantial economic losses and posing a serious public health threat through the contamination of animal-derived food products. Although probiotics are increasingly recognized as promising alternatives to antibiotics for controlling Salmonella infection, their mechanistic basis of protection remains insufficiently defined. Here, we evaluated the probiotic efficacy of Lactobacillus agilis LA-V4, a stress-tolerant strain isolated from vulture feces, in healthy Arbor Acres broilers and in a prophylactic model of S. Typhimurium infection. In healthy birds, LA-V4 supplementation enhanced mucosal immune responses and appeared to alleviate hepatic metabolic stress associated with rapid early growth. In S. Typhimurium-challenged broilers, LA-V4 markedly improved intestinal barrier integrity by upregulating the tight junction proteins ZO-1 and Occludin. Moreover, LA-V4 pretreatment was associated with a significantly lower relative abundance of Salmonella-assigned sequences in the cecal microbiota and partially ameliorated infection-associated microbial dysbiosis, as evidenced by decreased relative abundances of Firmicutes-related taxa, such as Lachnospiraceae and Erysipelotrichales, together with increased relative abundances of Lactobacillus and several putative short-chain fatty acid-producing taxa, including v9d2013_group, Phascolarctobacterium, and Fournierella. In hepatic tissue, LA-V4 restored autophagic activity, as reflected by increased LC3-II and Beclin1 expression and reduced p62 accumulation. Taken together, our findings identify L. agilis LA-V4 as a novel probiotic candidate that protects broilers against S. Typhimurium infection through coordinated regulation of the gut microbiota, intestinal barrier function, and hepatic autophagic responses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.